Torrent Pharma Fact Sheet, Torrent Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Torrent Pharma Fact Sheet    (TORR)



Here is the latest financial fact sheet of Torrent Pharma. For more details, see the Torrent Pharma quarterly results and Torrent Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

TORRENT PHARMA Price History

Price Rs 2,560.7
Mkt Cap Rs m 433,424
Vol '000 17.1
P/E X 36.2
P/CF X 41.1
EPS (TTM) Rs 70.7
% ch % 1.6
No. of shares m 169.26
% ch week % -5.3
% ch 1-mth % -4.9
% ch 12-mth % 42.7
52 week H/L Rs 3,040.0/1,619.0
(As on Oct 30, 2020 03:32:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

TORRENT PHARMA Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
TORRENT PHARMA EQUITY SHARE DATA
High Rs1,2321,7201,7681,5501,964 
Low Rs5231,1341,1861,1441,245 
Sales per share (Unadj.) Rs275.0394.5346.1351.6453.4 
Earnings per share (Unadj.) Rs44.4102.455.240.125.8 
Diluted earnings per shareRs44.4102.455.240.125.8 
Cash flow per share (Unadj.) Rs55.6116.573.364.262.3 
Dividends per share (Unadj.) Rs11.2540.0014.0014.0017.00 
Adj. dividends per shareRs11.2539.9914.0014.0017.00 
Dividend yield (eoy) %1.32.80.91.01.1 
Book value per share (Unadj.) Rs156.2206.5257.1273.1279.2 
Adj. book value per shareRs156.1206.4257.0273.1279.1 
Shares outstanding (eoy) m169.22169.22169.22169.22169.22 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x3.23.64.33.83.5 
Avg P/E ratio x19.813.926.833.662.2 
P/CF ratio (eoy) x15.812.320.121.025.8 
Price / Book Value ratio x5.66.95.74.95.7 
Dividend payout %25.439.125.434.965.9 
Avg Mkt Cap Rs m148,465241,435249,887227,897271,513 
No. of employees `00011.010.911.814.713.6 
Total wages/salary Rs m8,4188,4249,93411,35314,038 
Avg. sales/employee Rs Th4,212.46,129.64,971.54,047.55,642.6 
Avg. wages/employee Rs Th762.0773.4843.2772.31,032.4 
Avg. net profit/employee Rs Th679.81,591.3792.4461.3320.9 
TORRENT PHARMA INCOME DATA
Net Sales Rs m46,53566,76458,56959,49876,728 
Other income Rs m2,8562,2562,2332,988571 
Total revenues Rs m49,39069,02060,80262,48777,299 
Gross profit Rs m10,20227,33013,77313,49319,831 
Depreciation Rs m1,9072,3763,0694,0866,177 
Interest Rs m1,7521,8402,0563,0855,038 
Profit before tax Rs m9,39825,37110,8819,3109,187 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m0-1,93600-3,570 
Tax Rs m1,8886,1021,5452,5291,254 
Profit after tax Rs m7,50917,3339,3366,7814,363 
Gross profit margin %21.940.923.522.725.8 
Effective tax rate %20.124.114.227.213.6 
Net profit margin %16.126.015.911.45.7 
TORRENT PHARMA BALANCE SHEET DATA
Current assets Rs m40,98346,88248,79452,62350,375 
Current liabilities Rs m27,04632,85527,38352,02251,653 
Net working cap to sales %30.021.036.61.0-1.7 
Current ratio x1.51.41.81.01.0 
Inventory Days Days84749712192 
Debtors Days Days12579597768 
Net fixed assets Rs m34,72039,00742,07985,01683,648 
Share capital Rs m846846846846846 
"Free" reserves Rs m25,58334,09542,65545,37646,397 
Net worth Rs m26,43034,94143,50146,22247,244 
Long term debt Rs m21,72918,50122,40841,11539,129 
Total assets Rs m79,64190,57997,021142,432141,209 
Interest coverage x6.414.86.34.02.8 
Debt to equity ratio x0.80.50.50.90.8 
Sales to assets ratio x0.60.70.60.40.5 
Return on assets %11.621.211.76.96.7 
Return on equity %28.449.621.514.79.2 
Return on capital %23.247.319.614.212.3 
Exports to sales %30.443.3000 
Imports to sales %6.06.9000 
Exports (fob) Rs m14,13628,934000 
Imports (cif) Rs m2,8014,584000 
Fx inflow Rs m14,26529,18520,06614,58022,103 
Fx outflow Rs m5,1846,0215,3043,6005,522 
Net fx Rs m9,08123,16514,76210,98016,581 
TORRENT PHARMA CASH FLOW
From Operations Rs m 8,102 27,421 10,088 8,942 17,981 
From Investments Rs m -21,623 -8,379 -7,869 -47,070 -2,413 
From Financial Activity Rs m 12,123 -14,352 -1,929 34,174 -13,145 
Net Cashflow Rs m -1,399 4,375 177 -3,655 2,380 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 71.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 7.0%
FIIs 12.6%
ADR/GDR 0.0%
Free float 8.8%
Shareholders 26,511
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Torrent House, Off Ashram Road, Ahmedabad - 380 009
E-MAIL maheshagrawal@torrentpharma.com WEB www.torrentpharma.com
TELEPHONE (079) 2658 5090 FAX (079) 2658 2100
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR Deloitte Haskins & Sells
CHM: Sudhir Mehta COMP SEC: Mahesh Agarwal YEAR OF INC: 1973 BSE CODE: 500420 FV (Rs): 5 DIV YIELD (%): 0.7

More Pharmaceuticals Company Fact Sheets:   NATCO PHARMA  INDRAPRASTHA MEDICAL  DIVIS LABORATORIES  PFIZER  INDOCO REMEDIES  

Compare TORRENT PHARMA With:   NATCO PHARMA  INDRAPRASTHA MEDICAL  DIVIS LABORATORIES  PFIZER  INDOCO REMEDIES  

Compare TORRENT PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  




Today's Market

Sensex Ends 136 Points Lower; Telecom and Automobile Stocks Witness Selling(Closing)

Indian share markets witnessed volatile trading activity throughout the day and ended marginally lower.

Views on news

TORRENT PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 27.0% (Quarterly Result Update)

Oct 27, 2020 | Updated on Oct 27, 2020

For the quarter ended September 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 27.0% YoY). Sales on the other hand came in at Rs 20 bn (up 0.6% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6% (Quarterly Result Update)

Jul 31, 2020 | Updated on Jul 31, 2020

For the quarter ended June 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 48.6% YoY). Sales on the other hand came in at Rs 21 bn (up 1.7% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

My View on ITC (Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

PSU Banks Will Move Up Again (Profit Hunter)

Oct 27, 2020

My charts tell me PSU banks are set for a rebound.

PSU Stocks Are Looking Positive Now (Fast Profits Daily)

Oct 19, 2020

Has the market changed its opinion on PSUs?

One Cycle that Defines Everything in Markets (Profit Hunter)

Oct 23, 2020

Know this cycle to boost your profits in the market.

Markets are Always Right? (The Honest Truth)

Oct 30, 2020

Ajit Dayal on why you shouldn't let your guard down as an investor.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS